Skip to content

Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07804485
Enrollment
14
Registered
2026-09-04
Start date
2026-09-25
Completion date
2026-12-31
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echocardiography, Healthy, Healthy Adult, Hemodynamic Changes, High Altitude, Pulmonary Resistance

Keywords

Hypoxia, High altitude, Health, Echocardiography, Pulmonary resistance, Hemodynamics

Brief summary

To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in healthy individuals, who live permanently \>2600m.

Detailed description

The aim of this research is to investigate the pulmonary resistance (sPAP/CO) by echocardiography and other hemodynamic outcomes before and after relocation (high altitude near their living altitude vs. sea level) in healthy individuals, who permanently live at high altitude over 2600m.

Interventions

Descent from 2850m to sea level with a stay for 7 days

Sponsors

Silvia Ulrich Somaini
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Healthy individuals living permanently \> 2600m around Quito (Ecuador) will be assessed at 2850m and after relocation to sea level

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-80 years and of all genders * Permanent residence \> 2600 m * healthy: no self-perceived cardiopulmonary disease limiting daily activities * written informed consent to participate in the study.

Exclusion criteria

* Age \<18 years or \>80 years * People who cannot follow the study investigations * Participant permanently living \< 2600m. * Participant who traveled and stayed overnight at altitudes \<2000 m in the past 4 weeks. * any self-perceived cardiopulmonary disease limiting daily activities

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary resistance (sPAP/CO) after 7 days at sea levelFrom high altitude (2850m) to day 5-7 at sea levelDifference/change in sPAP/CO by echocardiography between 2850m and Day 5-7 at sea level in healthy individuals

Secondary

MeasureTime frameDescription
Tricuspid regurgitation velocity TRV after 7 days at sea levelFrom high altitude (2850m) to day 5-7 at sea levelDifference/change in tricuspid regurgitation velocity TRV between 2850m and Day 5-7 at sea level in healthy individuals
Cardiac output CO after 7 days at sea levelFrom high altitude (2850) to day 5-7 at sea levelDifference/change in cardiac output CO between 2850m and Day 5-7 at sea level in healthy individuals
Tricuspid annular plan systolic excursion TAPSE after 7 days at sea levelFrom high altitude (2850m) to day 5-7 at sea levelDifference/change in tricuspid annular plan systolic excursion TAPSE between 2850m and Day 5-7 at sea level in healthy individuals
Right ventricular strain after 7 days at sea levelFrom high altitude (2850m) to Day 5-7 at sea levelDifference/change in right ventricular strain between 2850m and day 5-7 at sea level in healthy individuals
Right atrial pressure RAP after 7 days at sea levelFrom high altitude (2850m) to Day 5-7 at sea levelDifference/change in right atrial pressure RAP between 2850m and day 5-7 at sea level in healthy individuals
Fractional area change FAC after 7 days at sea levelFrom high altitude (2850m) to Day 5-7 at sea levelDifference/change in fractional area change FAC between 2850m and day 5-7 at sea level in healthy individuals
PaO2 after 7 days at sea levelFrom high altitude (2850) to day 7 at sea levelDifference/change in PaO2 (arterial blood gas analysis) between 2850m and sea level in healthy individuals
PaCO2 after 7 days at sea levelFrom high altitude (2850) to day 7 at sea levelDifference/change in PaCO2 (arterial blood gas analysis) between 2850m and sea level in healthy individuals
Hemoglobin after 7 days at sea levelFrom high altitude (2850) to day 7 at sea levelDifference/change in hemoglobin (arterial blood gas analysis) between 2850m and sea level in healthy individuals
pH after 7 days at sea levelFrom high altitude (2850) to day 7 at sea levelDifference/change in pH (arterial blood gas analysis) between 2850m and sea level in healthy individuals
Acclimatization-Effect of pulmonary resistance (sPAP/CO) at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in pulmonary resistance (sPAP/CO) within a stay at sea level of 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of tricuspid regurgitation velocity TRV at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in tricuspid regurgitation velocity TRV within a stay at sea level of 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of cardiac output CO at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in cardiac output CO within a stay at sea level of 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of tricuspid annular plan systolic excursion TAPSE at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in tricuspid annular plan systolic excursion TAPSE within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of right ventricular strain at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in right ventricular strain within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of right atrial pressure RAP at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in right atrial pressure RAP within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of fractional area change FAC at sea levelFrom Day 2 to Day 5-7 at sea levelDifference/change in fractional area change FAC within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of PaO2 at sea levelFrom Day 2 to Day 7 at sea levelDifference/change in PaO2 (arterial blood gas analysis) within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of PaCO2 at sea levelFrom Day 2 to Day 7 at sea levelDifference/change in PaCO2 (arterial blood gas analysis) within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of hemoglobin at sea levelFrom Day 2 to Day 7 at sea levelDifference/change in hemoglobin (arterial blood gas analysis) within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals
Acclimatization-Effect of pH at sea levelFrom Day 2 to Day 7 at sea levelDifference/change in pH (arterial blood gas analysis) within a stay at sea level for 7 days (after relocation from high altitude) in healthy individuals

Countries

Switzerland

Contacts

CONTACTSilvia Ulrich, Prof. Dr. med.
silvia.ulrich@usz.ch+41442552220
CONTACTMichael Furian, Prof. Dr. sc. ETH
+41442552220
PRINCIPAL_INVESTIGATORSilvia Ulrich

University Hospital Zurich, Departement of Pulmonology

PRINCIPAL_INVESTIGATORRodrigo Hoyos

Hospital Carlos Andrade Marin of Quito, Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026